share_log

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

4：持股變動聲明-高管 Kupiec James William
美股sec公告 ·  05/22 16:55
Moomoo AI 已提取核心訊息
James William Kupiec, the Chief Medical Officer of Cassava Sciences Inc. (ticker: SAVA.US), was reported to have engaged in a transaction involving the company's stock on May 20, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Consequently, the number of shares held by Kupiec after the action remains unknown.
James William Kupiec, the Chief Medical Officer of Cassava Sciences Inc. (ticker: SAVA.US), was reported to have engaged in a transaction involving the company's stock on May 20, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Consequently, the number of shares held by Kupiec after the action remains unknown.
據報道，木薯科學公司（股票代碼：SAVA.US）首席醫學官詹姆斯·威廉·庫皮克於2024年5月20日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。因此，Kupiec在行動後持有的股票數量仍然未知。
據報道，木薯科學公司（股票代碼：SAVA.US）首席醫學官詹姆斯·威廉·庫皮克於2024年5月20日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。因此，Kupiec在行動後持有的股票數量仍然未知。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息